Immunotherapy Program

News

2023

Novel T-cell therapy effective against common viruses after stem cell transplantation (HemOnc Today - January 12, 2023)

An investigational T-cell therapy shows promise against six viral infections common after stem cell transplants (American Association for Cancer Research - January 11, 2023)

2022

Pilot grants awarded to researchers for innovative therapies (September 7, 2022 - Texas Children's Hospital)

See How LLS^® Is Funding Life-Saving Research (Leukemia & Lymphoma Society - September 5, 2022)

New study shows “Living Drug” can provide a lasting cure for cancer (Leaps - March 23, 2022)

2021

Athenex, Texas Children’s Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine present new clinical data on GD2 CAR-NKT cells in neuroblastoma at ASGCT Annual Meeting (Athenex - May 17, 2021)

Baylor and TCH researchers honored with AACR Team Science Award (Baylor College of Medicine - April 15, 2021)

Administering CAR T-cell therapy to younger patients requires ‘ongoing and open’ relationships (Healio - March 24, 2021)

Despite challenges, CAR-T may have ‘expanded role’ for children (Healio - February 23, 2021)

Curing Kids Cancer gives $1.5 Million to childhood cancer research projects (Digital Journal - February 4, 2021)

2020

The Faris Foundation grant funds research for advanced sarcoma clinical trial (Baylor College of Medicine - December 4, 2020)

Hegde and team receive funding from The Faris Foundation for advanced sarcoma clinical trial (Texas Children's Hospital - December 2, 2020)

CAR NKT cells, a promising step forward in the treatment of solid tumors ( Baylor College of Medicine - November 10, 2020)

CAR NKT cells offer a promising novel immunotherapy for solid tumors (Baylor College of Medicine - October 12, 2020)

Fighting cancer with rejection-resistant, ‘off-the-shelf’ therapeutic T cells (Baylor College of Medicine - August 20, 2020)

CAR T cell immunotherapy results in patient recovery (Baylor College of Medicine - July 15, 2020)

New approach called nano-radiomics assesses changes in the tumor microenvironment (Baylor College of Medicine - July 13, 2020)

CAR T cell therapy promising treatment for recurrent pediatric brain cancer (Medical Dialogues - May 3, 2020)

Promising new treatment for recurrent pediatric brain cancer (Baylor College of Medicine - April 27, 2020)

Texas Children’s unveils Sky High for Kids Immunotherapy Center on 7 West Tower (Texas Children's Hospital - February 18, 2020)

2019

Sky-high efforts: Nonprofit raises money for pediatric cancer (Midland Reporter-Telegram - November 26, 2019)

Cancer Center on forefront of cutting-edge research, clinical trials (Texas Children's Hospital - September 17, 2019)

Body of Work podcast: Harnessing the body’s immune system to fight cancer (Baylor College of Medicine - September 16, 2019)

Baylor awarded CPRIT grants to support cancer research (Baylor College of Medicine - August 23, 2019)

Professor optimistic cancer will become less life-threatening (Otago Daily Times - August 14, 2019)

Trial underway in US uses CRISPR gene-editing in people with severe sickle cell disease (CNN Health - July 30, 2019)

New genetic weapons challenge sickle cell disease (ScienceDaily - June 3, 2019)

New experimental therapy CAR NKT-cells tested In cancer patients for the first time (Forbes - May 1, 2019)

Joseph, Hegde receive Immunotherapy Scholar Award from the Faris Foundation (Texas Children's Hospital - April 9, 2019)

Cancer treatment uses genetically modified cells to fight tumors (CBS - April 1, 2019)

Heslop receives lifetime achievement award (Texas Children's Hospital - March 11, 2019)

Houston-area physicians, scientists receive a combined $38.1M for cancer research (Houston Business Journal - February 22, 2019)

Marker Therapeutics congratulates Helen E. Heslop, MD, DSc (Hon) on receiving the ASBMT Lifetime Achievement Award (MarketWatch - February 21, 2019)

CPRIT changing lives of childhood cancer survivors (mySA - February 17, 2019)

2018

$5 million grant to expand blood cancer therapy options (Baylor College of Medicine - October 18, 2018)

First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT) (Cell Medica - September 27, 2018)

CPRIT awards $6 million to find new biomarkers and therapies for childhood liver cancers (Texas Children's Hospital - September 19, 2018)

Baylor awarded CPRIT Grants for research, recruitment (Baylor College of Medicine - August 27, 2018)

First-in-human clinical trial aims to treat neuroblastoma (Baylor College of Medicine - June 15, 2018)

How 'Sky High' is raising millions for cancer research (ABC 13 KTRK - May 21, 2018)

2017

Alex’s Lemonade Stand funds Phase 1 neuroblastoma trial  (Baylor College of Medicine - December 04, 2017)

Clinical trial shows ready-to-use cells are safe and effective to treat viral infections  (Baylor College of Medicine - August 07, 2017)

First-of-its-kind therapy has cancer experts excited  (Houston Chronicle - July 13, 2017)

Heslop to lead cell and gene therapy society  (Baylor College of Medicine - May 23, 2017)

Clinical trial results show benefit of brain cancer therapy  (Baylor College of Medicine - April 24, 2017)

Grant to fund potential new glioblastoma treatment research (Texas Children's Hospital - April 08, 2017)

Texas Children’s Cancer Center to host neuroblastoma research conference (Texas Children's Hospital - April 08, 2017)

International Neuroblastoma Research Conference will be May 3-5, 2017 (Texas Children's Hospital - January 17, 2017)

2016

CPRIT awards additional $7 million to individual investigators  (Baylor College of Medicine - November 21, 2016)

Dr. Malcolm Brenner named to National Academy of Medicine (Texas Children's Hospital - October 18, 2016)

Special T cells that target solid tumors offer potential treatment for pediatric and adult cancers (Texas Children's Hospital - September 20, 2016)

Selective predators: Natural killer T cells take aim at solid tumors (Texas Children's Hospital - September 13, 2016)

Children’s cancer research at Baylor, Texas Children’s Cancer Center funded by St. Baldrick’s Foundation (Texas Children's Hospital - August 23, 2016)

Researchers uncover marker important to effectiveness of natural killer T cells (Texas Children's Hospital - May 20, 2016)

Shine a light on neuroblastoma  (TMC News - February 03, 2016)

2015

Neuroblastoma research at Baylor receives funding through support of Today show viewers (Texas Children's Hospital - December 18, 2015)